Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleProspective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection
- Where
- Tongling
- Age
- 40 years and over
- People
- 15,000
- Run by
- Fudan University
See details and how to joinNCT06943781 - No phaseNot yet taking people in ChinaEradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
- Where
- Tongling
- Age
- 40 years and over
- People
- 4,824
- Run by
- Fudan University
See details and how to joinNCT06943794 - No phaseTaking peopleProspective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
- Where
- Tongling
- Age
- 40 years and over
- People
- 15,000
- Run by
- Fudan University
See details and how to joinNCT06943807 - Phase 1Taking peopleClinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
- Where
- Nanjing
- Age
- 18 years to 70 years
- People
- 18
- Run by
- Jia Wei
See details and how to joinNCT07298200 - Phase 1/2Taking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - Phase 1Not yet taking people in ChinaClinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Beijing Immunochina Medical Science & Technology Co., Ltd.
See details and how to joinNCT07406984 - Phase 2Taking peoplePh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 258
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT05671822 - Phase 3Not yet taking people in ChinaThe Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 144
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07406815 - Phase 3Taking peopleA Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Shanghai, Shenyang
- Age
- 18 years to 75 years
- People
- 600
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07118527 - Phase 2Taking peopleSafety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 68
- Run by
- Dai, Guanghai
See details and how to joinNCT07392346 - Phase 2Not yet taking people in ChinaShort-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 22
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07403435 - No phaseTaking peopleThe Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
- Where
- Shanghai
- Age
- 18 years and over
- People
- 300
- Run by
- Fudan University
See details and how to joinNCT07400354 - Phase 2Not yet taking people in ChinaMegestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 48
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07391826 - No phaseTaking peopleAlbumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 250
- Run by
- Fudan University
See details and how to joinNCT07389876 - Phase 1Taking peopleA Study of SH009 Injection in Patients With Advanced Solid Tumors.
- Where
- Shanghai
- Age
- 18 years and over
- People
- 150
- Run by
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
See details and how to joinNCT07390838 - Phase 2Not yet taking people in ChinaNeoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 66
- Run by
- Ji Yongling
See details and how to joinNCT07385664 - Phase 1/2Taking peopleA Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 45
- Run by
- Tang-Du Hospital
See details and how to joinNCT07385001 - Phase 3Not yet taking people in ChinaNeoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 390
- Run by
- Tang-Du Hospital
See details and how to joinNCT06952621 - Early phase 1Taking peopleA Clinical Study of GK02 in Malignant Ascites
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Beijing Geekgene Technology Co., LTD
See details and how to joinNCT07378436 - Phase 2Not yet taking people in ChinaIndocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy
- Where
- Chongqing
- Age
- 18 years to 80 years
- People
- 73
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07376876 - Phase 1/2Taking peopleAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
- Where
- Beijing, Hangzhou, Zhengzhou
- Age
- 18 years and over
- People
- 266
- Run by
- Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07371663 - Phase 2Not yet taking people in ChinaPerioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 154
- Run by
- Sichuan University
See details and how to joinNCT07374250 - Early phase 1Enrolling by invitationBased on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 65
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07371247 - Phase 3Taking peopleAdjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
- Where
- Shanghai, Shaoguan
- Age
- 18 years to 80 years
- People
- 387
- Run by
- Ruijin Hospital
See details and how to joinNCT07366528 - Phase 1Taking peopleStudy of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 18
- Run by
- Weijia Fang, MD
See details and how to joinNCT06821048